Abstract:Macrophage mitochondrial dysfunction is associated with immunosuppression and poor prognosis of septic patients. Mitochondrial fragmentation drives mitochondrial dysfunction. Our previous study has found that S1PR2 regulates macrophage phagocytosis during sepsis, while the role of S1PR2 in immunosuppression and the mechanisms remain further studied. This study aimed to unveil the relationship between macrophage mitochondrial fragmentation and sepsis-induced immunosuppression, as well as the S1PR2-related mechanisms thereof. Peripheral blood monocytes were collected from healthy controls (n = 12), nonseptic critical controls (n = 13) and septic patients (n = 19). Peritoneal macrophages were harvested from wildtype and S1pr2-/- mice (MMRRC strain iD, 12830) after cecal ligation and puncture (CLP). Mitochondrial ultrastructure was evaluated using transmission electron microscopy. The impact of mitochondrial ultrastructure alteration on immunosuppression of monocytes-macrophages was evaluated. Compared with nonseptic and healthy controls, peripheral blood monocytes from septic patients exhibited increased S1PR2 expression, mitochondrial fragmentation, and mitochondrial dysfunction. Mitochondrial fragmentation was negatively associated with HLA-DR expression. S1PR2 expression was positively correlated with mitochondrial fragmentation and negatively correlated with HLA-DR expression. In mice subjected to CLP, S1PR2 depletion ameliorated macrophage mitochondrial fragmentation and dysfunction, boosted immunity, and improved survival. Mechanistically, in response to sepsis, S1PR2 activates ROCK I to induce Drp1 phosphorylation, resulting in Drp1-dependent mitochondrial fragmentation of macrophages. Drp1 inhibition by Mdivi-1 mitigated S1PR2-induced macrophage immunosuppression and improved the prognosis of mice following CLP. In conclusion, S1PR2-induced mitochondrial fragmentation is a crucial factor mediating septic immunosuppression, highlighting its potential as a promising therapeutic target in sepsis.

[Research of Progress of Mitochondria in the Pathogenesis of Sepsis].

[Research progress of mitochondrial dysfunction in the pathogenesis of septic acute kidney injury].

Research Progress in the Changes and Management of Myocardial Mitochondria During Sepsis

Research progress on the role of mitochondrial quality control in sepsis associated encephalopathy

Mechanism of Mitophagy and Its Role in Sepsis Induced Organ Dysfunction: A Review

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure

Progress in the Mechanism of Mitochondrial Dysfunction in Septic Cardiomyopathy

Research progress of the mechanism of myocardial energy metabolism disorder in sepsis

Research Progress on Mechanisms and Treatment of Sepsis-Induced Myocardial Dysfunction

Mitochondrial dysfunction and resuscitation in sepsis

[Research Progress on the Role of Mitochondrial Dynamics Disorder in Sepsis-Associated Acute Kidney Injury].

Potential Therapy Strategy: Targeting Mitochondrial Dysfunction in Sepsis

Mitochondrial Damage in Sepsis

Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy

Mitochondria-Derived Damage-Associated Molecular Patterns In Sepsis: From Bench To Bedside

Molecular mechanisms of Sepsis attacking the immune system and solid organs

[Pathogenesis, Diagnosis, and Management for Sepsis: Update Progress and Scientific Problems].

Macrophage S1PR2 Drives Sepsis-induced Immunosuppression by Exacerbating Mitochondrial Fragmentation

Energy metabolism: from physiological changes to targets in sepsis-induced cardiomyopathy

[Research progress on the correlation between intestinal microecology and sepsis]